Phase I clinical and pharmacokinetic study of the oral platinum analogue JM216 given daily for 14 days

Sessa, C.; Minoia, C.; Ronchi, A.; Zucchetti, M.; Bauer, J.; Borner, M.; De Jong, J.; Pagani, O.; Renard, J.; Weil, C.; D'Lncalci, M. (1998). Phase I clinical and pharmacokinetic study of the oral platinum analogue JM216 given daily for 14 days. Annals of oncology, 9(12), pp. 1315-1322. Oxford University Press 10.1023/A:1008441416790

[img]
Preview
Text
9-12-1315.pdf - Published Version
Available under License Publisher holds Copyright.

Download (757kB) | Preview

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Medical Oncology

UniBE Contributor:

Borner, Markus

Subjects:

600 Technology > 610 Medicine & health

ISSN:

0923-7534

Publisher:

Oxford University Press

Language:

English

Submitter:

Markus Müller

Date Deposited:

01 Oct 2018 13:45

Last Modified:

23 Oct 2019 05:22

Publisher DOI:

10.1023/A:1008441416790

BORIS DOI:

10.7892/boris.115559

URI:

https://boris.unibe.ch/id/eprint/115559

Actions (login required)

Edit item Edit item
Provide Feedback